Mitsubishi Tanabe Pharma America to Showcase ALS Research at 2022 American Academy of Neurology Annual Meeting
Presentations Include Real-World Data on RADICAVA® (edaravone) and Results from a Global Phase 3 Study of Investigational Oral Edaravone JERSEY CITY, N.J., April 1, 2022 — Mitsubishi Tanabe Pharma America, Inc. (MTPA)…